Klebsiella K15 Antibodies

Santa Cruz Biotechnology features a diverse variety of Klebsiella K15 monoclonal antibodies for research focused on understanding the role of K15 capsular polysaccharide in Klebsiella infections. Klebsiella K15 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). K15 polysaccharide serves as a critical virulence factor that enhances the pathogenicity of Klebsiella species by evading the host immune response. Understanding the function of K15 antigen is essential for developing targeted therapies and vaccines against Klebsiella infections, which are known to cause severe healthcare-associated infections. Research involving K15 capsular polysaccharide can reveal important insights into bacterial resistance mechanisms. Investigating K15 antigen expression patterns helps scientists better understand host-pathogen interactions during infection. Exploring K15 polysaccharide structure and function contributes to the development of novel therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge about bacterial pathogenesis and potential treatment strategies.